NDC 10702-283

ColPrep Kit

Sodium Sulfate, Potassium Sulfate, And Magnesium Sulfate For Oral Solution

ColPrep Kit is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Kvk-tech, Inc.. The primary component is Sodium Sulfate; Potassium Sulfate; Magnesium Sulfate.

Product ID10702-283_767105a0-65a5-444a-989f-f766b0851c2a
NDC10702-283
Product TypeHuman Prescription Drug
Proprietary NameColPrep Kit
Generic NameSodium Sulfate, Potassium Sulfate, And Magnesium Sulfate For Oral Solution
Dosage FormPowder, For Solution
Route of AdministrationORAL
Marketing Start Date2016-12-27
Marketing CategoryNDA / NDA
Application NumberNDA204553
Labeler NameKVK-Tech, Inc.
Substance NameSODIUM SULFATE; POTASSIUM SULFATE; MAGNESIUM SULFATE
Active Ingredient Strength18 g/22.7g; g/22.7g; g/22.7g
Pharm ClassesOsmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 10702-283-23

2 BOTTLE, PLASTIC in 1 CARTON (10702-283-23) > 22.7 g in 1 BOTTLE, PLASTIC
Marketing Start Date2016-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10702-283-23 [10702028323]

ColPrep Kit POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA204553
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-12-27
Marketing End Date2019-01-24

Drug Details

Active Ingredients

IngredientStrength
SODIUM SULFATE17.5 g/22.7g

OpenFDA Data

SPL SET ID:bd9f13a9-0f13-4809-ad70-8f3cc2bd19bd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1120068
  • 1001689
  • UPC Code
  • 0310702083233
  • Pharmacological Class

    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Magnesium Ion Exchange Activity [MoA]
    • Osmotic Laxative [EPC]
    • Osmotic Activity [MoA]
    • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
    • Increased Large Intestinal Motility [PE]
    • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.